Association of polymorphisms in genes of the homologous recombination dna repair pathway and thyroid cancer risk

Thyroid

Volumn 19, Issue 10, 2009, Pages 1067-1075

  Bastos, Helder Novais ^a   Antão, Mónica Rego ^a   Silva, Susana N ^a   Azevedo, Ana Paula ^b   Manita, Isabel ^c   Teixeira, Valdemar ^b   Pina, Julieta Esperança ^a,b   Gil, Octávia Monteiro ^d   Ferreira, Teresa Cruz ^e   Limbert, Edward ^e   Rueff, José ^a   Gaspar, Jorge Francisco ^a  

^a UNIVERSIDADE NOVA DE LISBOA   (Portugal)

^b Hospital of Santo Francisco Xavier   (Portugal)

^c HOSPITAL GARCIA DE ORTA   (Portugal)

^d INSTITUTO TECNOLÓGICO E NUCLEAR   (Portugal)

^e INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

NIBRIN; NUCLEIC ACID BINDING PROTEIN; RAD51 PROTEIN; UNCLASSIFIED DRUG; XRCC2 PROTEIN; XRCC3 PROTEIN;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA POLYMORPHISM; DNA RECOMBINATION; DNA REPAIR; FEMALE; GENOTYPE; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; POPULATION RESEARCH; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THYROID CANCER;

ADULT; AGED; ALLELES; CASE-CONTROL STUDIES; DNA REPAIR; DNA, NEOPLASM; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; SMOKING; THYROID NEOPLASMS;

EID: 70350650666     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.0099     Document Type: Article

References (40)

1. Cancer Facts and Figures 2008. American Cancer Society, Atlanta, GA.
2. Schlumberger M, Cailleux AF, Suarez HG, Vathaire F 1999 Irradiation and second cancers: the thyroid as a case in point. Acad Sci Paris Sci de la vie 32:205-213.
3. Ron E, Lubin JH, Shore RE, Mabuchi K, Modan B, Pottern LM, Schneider AB, Tucker MA, Boice JD Jr. 1995 Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. Radiat Res 141:259-277.
4. Lund E, Galanti MR 1999 Incidence of thyroid cancer in Scandinavia following fallout from atomic bomb testing: an analysis of birth cohorts. Cancer Causes Control 10:181-187.
5. Kirsch-Volders M, Mateuca RA, Roelants M, Tremp A, Zeiger E, Bonassi S, Holland N, Chang WP, Aka PV, Deboeck M, Godderis L, Haufroid V, Ishikawa H, Laffon B, Marcos R, Migliore L, Norppa H, Teixeira JP, Zijno A, Fenech M 2006 The effects of GSTM1 and GSTT1 polymorphisms on micronucleus frequencies in human lymphocytes in vivo. Cancer Epidemiol Biomark Prev 15:1038-1042.
6. Sarasin A, Bounacer A, Lepage F, Schlumberger M, Suarez HG 1999 Mechanisms of mutagenesis in mammalian cells. Application to human thyroid tumours. C R Acad Sci III 322:143-149.
7. Rabes HM, Demidchik EP, Sidorow JD, Lengfelder E, Beimfohr C, Hoelzel D, Klugbauer S 2000 Pattern of radiation-induced RET and NTRK1 rearrangements in 191 post-Chernobyl papillary thyroid carcinomas: biological, phenotypic and clinical implications. Clin Cancer Res 6: 1093-1103.
8. Aka P, Mateuca R, Buchet JP, Thierens H, Kirsch-Volders M 2004 Are genetic polymorphisms in OGG1, XRCC1 and XRCC3 genes predictive for the DNA strand break repair phenotype and genotoxicity in workers exposed to low dose ionising radiations? Mutat Res 556:169-181.
9. Hu JJ, Smith TR, Miller MS, Mohrenweiser HW, Golden A, Case LD 2001 Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity. Carcinogenesis 22:917-922.
10. Thompson LH, Schild D 2001 Homologous recombinational repair of DNA ensures mammalian chromosome stability. Mutat Res 477:131-153.
11. Liu Y, Tarsounas M, O'Regan P, West SC 2007 Role of RAD51C and XRCC3 in genetic recombination and DNA repair. J Biol Chem 282:1973-1979.
12. Sonoda E, Sasaki MS, Buerstedde JM, Bezzubova O, Shinohara A, Ogawa H, Takata M, Yamaguchi-Iwai Y, Takeda S 1998 Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death. EMBO J 17:598-608.
13. Masson J, Tarsounas MC, Stasiak AZ, Stasiak A, Shah R, McIlwraith MJ, Benson FE, West SC 2001 Identification and purification of two distinct complexes containing the five RAD51 paralogs. Genes Dev 15:3296-3307.
14. Wiese C, Collins DW, Albala JS, Thompson LH, Kronenberg A, Schild D 2002 Interactions involving the RAD51 paralogs RAD51c and XRCC3 in human cells. Nucleic Acids Res 30:1001-1008. (Pubitemid 34679669)
15. Liu N, Schild D, Thelen MP, Thompson LH 2002 Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs in human cells. Nucleic Acids Res 30:1009-1015.
16. Bakkenist CJ, Kastan MB 2003 DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 421:499-506.
17. Berkovich E, Monnat RJ, Kastan MB 2007 Roles of ATM and NBS1 in chromatin structure modulation and DNA doublestrand break repair. Nat Cell Biol 9:683-690.
18. Williams RS, Williams JS, Tainer JA 2007 Mre11-Rad50-Nbs1 is a keystone complex connecting DNA repair machinery, double-strand break signalling, and the cromatin template. Biochem Cell Biol 85:509-520.
19. Helleday T, Lo J, van Gent DC, Engelward BP 2007 DNA double-strand break repair: from mechanistic understanding to cancer treatment. DNA Repair 6:923-935.
20. Kuschel B, Auranen A, McBride S, Novik KL, Antoniou A, Lipscombe JM, Day NE, Easton DF, Ponder BA, Pharoah PD, Dunning A 2002 Variants in DNA double-strand break repair genes and breast cancer susceptibility. Hum Mol Gen 11:1399-1407.
21. Matullo G, Guarrera S, Carturan S, Peluso M, Malaveille C, Davico L, Piazza A, Vineis P 2001 DNA repair gene polymorphisms, bulky DNA adducts in white blood cells and bladder cancer in a case-control study. Int J Cancer 92:562-567.
22. Figueroa JD, Malats N, Rothman N, Real FX, Silverman D, Kogevinas M, Chanock S, Yeager M, Welch R, Dosemeci M, Tardón A, Serra C, Carrato A, Garcýa-Closas R, Castaño- Vinyals G, Garcýa-Closas M 2007 Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis 28:1788-1793. (Pubitemid 47289043)
23. Costa S, Pinto D, Pereira D, Rodrigues H, Cameselle-Teijeiro J, Medeiros R, Schmitt F 2007 DNA repair polymorphisms might contribute differentially on familial and sporadic breast cancer susceptibility: a study on a Portuguese population. Breast Cancer Res Treat 103:209-217.
24. Rollinson S, Smith AG, Allan JM, Adamson PJ, Scott K, Skibola CF, Smith MT, Morgan GJ 2007 RAD51 homologous recombination repair gene haplotypes and risk of acute myeloid leukaemia. Leuk Res 31:169-174.
25. Benhamou S, Tuimala J, Bouchardy C, Dayer P, Sarasin A, Hirvonen A 2004 DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int J Cancer 112:901-904.
26. Hsu HM, Wang HC, Chen ST, Hsu GC, Shen CY, Yu JC 2007 Breast cancer risk is associated with the genes encoding the DNA double-strand break repair Mre11=Rad50=Nbs1 complex. Cancer Epidemiol Biomark Prev 16:2024-2032.
27. Ziólkowska I, Mosor M, Wierzbicka M, Rydzanicz M, Pernak-Schwarz M, Nowak J 2007 Increased risk of larynx cancer in heterozygous carriers of the I171V mutation of the NBS1 gene. Cancer Sci 98:1701-1705.
28. Ryk C, Kumar R, Thirumaran RK, Hou SM 2006 Polymorphisms in the DNA repair genes XRCC1, APEX1, XRCC3 and NBS1, and the risk for lung cancer in never- and ever-smokers. Lung Cancer 54:285-292.
29. Thirumaran RK, Bermejo JL, Rudnai P, Gurzau E, Koppova K, Goessler W, Vahter M, Leonardi GS, Clemens F, Fletcher T, Hemminki K, Kumar R 2006 Single nucleotide polymorphisms in DNA repair genes and basal cell carcinoma of skin. Carcinogenesis 27:1676-1681.
30. Lange K, Cantor R, Horvath S, Perola M, Sabatti C, Sinsheimer J, Sobel E 2001 Mendel version 4.0: A complete package for the exact genetic analysis of discrete traits in pedigree and population data sets. Am J Hum Genet 69(Supplement):504.
31. Schlumberger MJ 1998 Papillary and follicular thyroid carcinoma. N Engl J Med 338:297-306.
32. Auranen A, Song H, Waterfall C, Dicioccio RA, Kuschel B, Kjaer SK, Hogdall E, Hogdall C, Stratton J, Whittemore AS, Easton DF, Ponder BA, Novik KL, Dunning AM, Gayther S, Pharoah PD 2005 Polymorphisms in DNA repair genes and epithelial ovarian cancer risk. Int J Cancer 117:611-618. (Pubitemid 41504549)
33. Sturgis EM, Zhao C, Zheng R, Wei Q 2005 Radiation response genotype and risk of differentiated thyroid cancer: a case-control analysis. Laryngoscope 115:938-945.
34. Shen H, Sturgis EM, Dahlstrom KR, Zheng Y, Spitz MR, Wei Q 2002 A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: a casecontrol analysis. Int J Cancer 99:869-872. (Pubitemid 34575706)
35. Manuguerra M, Saletta F, Karagas MR, Berwick M, Veglia F, Vineis P, Matullo G 2006 XRCC3 and XPD=ERCC2 single nucleotide polymorphisms and the risk of cancer: a huge review. Am J Epidemiol 164:297-302.
36. Kurumizaka H, Enomoto R, Nakada M, Eda K, Yokoyama S, Shibata T 2003 Region and amino acid residues required for Rad51C binding in the human Xrcc3 protein. Nucleic Acids Res 31:4041-4050.
37. Schild D, Lio Y, Collins DW, Tsomondo T, Chen DJ 2000 Evidence for simultaneous protein interactions between human Rad51 paralogs. J Biol Chem 275:16443-16449.
38. Chen GL, Vallender EJ, Miller GM 2008 Functional characterization of the human TPH2 50 regulatory region: untranslated region and polymorphisms modulate gene expression in vitro. Hum Genet 122:645-657.
39. Takata M, Sasaki MS, Tachiiri S, Fukushima T, Sonoda E, Schild D, Thompson LH, Takeda S 2001 Chromosome instability and defective recombinational repair in knock-out mutants of the five RAD51 paralogs. Mol Cell Biol. 21:2858-2866.
40. Gudmundsson J, Sulem P, Gudbjartsson DF, Jonasson JG, Sigurdsson A, Bergthorsson JT, He H, Blondal T, Geller F, Jakobsdottir M, Magnusdottir DN, Matthiasdottir S, Stacey SN, Skarphedinsson OB, Helgadottir H, Li W, Nagy R, Aguillo E, Faure E, Prats E, Saez B, Martinez M, Eyjolfsson GI, Bjornsdottir US, Holm H, Kristjansson K, Frigge ML, Kristvinsson H, Gulcher JR, Jonsson T, Rafnar T, Hjartarsson H, Mayordomo JI, de la Chapelle A, Hrafnkelsson J, Thorsteinsdottir U, Kong A, Stefansson K 2009 Common variants on 9q22.33 and 14q13.3 predispose to thyroid cancer in European populations. Nat Genet 41:460-464.